Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K/AKT/MAPK signaling pathway

27 Dec 2023

Abstract excerpt

In the treatment of unresectable advanced hepatocellular carcinoma (HCC), cisplatin is administered transhepatic arterially for local treatment, but the clinical application of cisplatin drugs is frequently hindered by the emergence of drug resistance. Kinesin family member 2C( KIF2C ) has been shown as oncogene in a variety of tumors. Nevertheless, its effect on cisplatin sensitivity has yet to be ascertained....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Microtubule and mitosis dynamics
Share to Protein Tyrosine Phosphatases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38170762
DOI: 10.1097/cad.0000000000001563

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K/AKT/MAPK signaling pathwayPMID 38170762Read ↗

Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells.Semantic proximity Read ↗

Study on the mechanism of KIF2C/PLK1 in the growth and metastasis of oral squamous cell carcinomaSemantic proximity Read ↗

KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathwaySemantic proximity Read ↗

KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3pSemantic proximity Read ↗

Potential Value of the Motor Protein Family KIF as a Diagnostic & Prognostic Marker for Human Hepatocellular Carcinoma: a Prospective ResearchSemantic proximity Read ↗

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCCSemantic proximity Read ↗

Bioinformatics Analysis of Kinesin Family Member 2C in Human Tumors: Novel Prognostic Biomarker and Tumor Microenvironment RegulatorSemantic proximity Read ↗

KIFC1 in cancer: Understanding its expression, regulation, and therapeutic potentialSemantic proximity Read ↗

Role of KIF2A in the progression and metastasis of human gliomaSemantic proximity Read ↗

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.Semantic proximity Read ↗

UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cellsSemantic proximity Read ↗

BIRC5 as a master regulator in HCC: unraveling its role in tumor survival and therapeutic potentialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.